Skip to main content
. 2021 May 9;31(11):8168–8186. doi: 10.1007/s00330-021-08003-8

Table 1.

Criteria to evaluate the quality of included studies

Quality items Signaling questions
Type of cohort study Does the study have a prospective or retrospective design?
Method of patient selection Was a consecutive, randomly selected, or obviously representative series of patients included?
Patient spectrum Were selection criteria for CTPA reported?
Blinded assessment of outcome Were CTPA interpreters blinded to clinical information (i.e., study purpose or COVID-19 status of patients)?